Aquestive Therapeutics, Inc.
AQST
Revenue
20.10M
▲8.05M▲66.76%
3 Months ChangeAssets
117.61M
▼-11.92M▼-9.20%
3 Months ChangeLiabilities
153.08M
▼-12.74M▼-7.68%
3 Months ChangeFree Cash Flow
-10.41M
▼-19.23M▼-218.14%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0001628280-24-043761
2024-10-24
Form 8-K
ID: 0001628280-24-043505
2024-10-16
Form 8-K
ID: 0001628280-24-042948
2024-09-27
Form 8-K
ID: 0001628280-24-041432
2024-09-09
Form 8-K
ID: 0001628280-24-039783
2024-08-14
Form 8-K
ID: 0001628280-24-037053
2024-08-06
Form 10-Q
ID: 0001628280-24-035225
2024-08-06
Form 8-K
ID: 0001628280-24-035223
2024-07-25
Form 8-K
ID: 0001628280-24-032917
2024-06-21
Form 8-K
ID: 0001628280-24-029340